InvestorsHub Logo
Followers 49
Posts 11391
Boards Moderated 0
Alias Born 06/15/2014

Re: DAR53 post# 422365

Wednesday, 03/20/2024 9:13:31 AM

Wednesday, March 20, 2024 9:13:31 AM

Post# of 426509
DAR, after reading the couple of posts describing the DRL comments about their icosapent ethyl, I wanted to respond in the same fashion as you. First, I wanted to find a listing of all their drugs and their respective sales in the U.S., but I could not find that data. My educated assumption has to be that IPE is one of their lowest selling drugs, so calling their IPE a "key" product seems rather non-sensical. Unless they see something for the future, but that seems rather unlikely considering these morons jumped in way before Amarin could develop the market here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News